R Holman
About
In The Last Decade
R Holman
7 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Endocrinology, Diabetes and Metabolism 959
- Cardiology and Cardiovascular Medicine 732
- Surgery 250
- Ophthalmology 228
- Radiology, Nuclear Medicine and Imaging 210
Countries citing papers authored by R Holman
This map shows the geographic impact of R Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Holman more than expected).
Fields of papers citing papers by R Holman
This network shows the impact of papers produced by R Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Holman. The network helps show where R Holman may publish in the future.
Co-authorship network of co-authors of R Holman
This figure shows the co-authorship network connecting the top 25 collaborators of R Holman. A scholar is included among the top collaborators of R Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Holman. R Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Stimulatory effects of the long-acting kisspeptin analogue TAK-448 on serum testosterone in men with type 2 diabetes and hypogonadotropic hypogonadism | 1 |
| 2 | Evaluation of the one-year efficacy, safety and glycaemic effects of evolocumab (AMG 145) in 4,802 subjects with, at high risk for, or at low risk for, diabetes mellitus | 6 |
| 3 | 62 | |
| 4 | Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities. Results of screening over 39,000 subjects for NAVIGATOR | 6 |
| 5 | Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS | 2 |
| 6 | Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. breakdown → | 1604 |
| 7 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.